Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of pharmaceuticals targeting cancer and inflammatory diseases. Its structure allows for selective binding to ATP sites in protein kinases, making it valuable in drug discovery programs focused on tyrosine kinase and cyclin-dependent kinase modulation. Also employed in research settings to design potent and selective small-molecule inhibitors for cellular signaling pathways.